Redox proteomics studies of in vivo amyloid beta-peptide animal models of Alzheimer's disease:: Insight into the role of oxidative stress

被引:18
|
作者
Sultana, Rukhsana [1 ,2 ]
Butterfield, D. Allan [1 ,2 ]
机构
[1] Univ Kentucky, Ctr Membrane Sci, Dept Chem, Lexington, KY 40506 USA
[2] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40506 USA
关键词
Alzheimer's disease; amyloid beta-peptide; Caenorhabditis elegans; canine; oxidative stress;
D O I
10.1002/prca.200780024
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Alzheimer's disease (AD) is an age-related neurodegenerative disease. AD is characterized by the presence of senile plaques, neurofibrillary tangles, and synaptic loss. Amyloid P-peptide (AP), a component of senile plaques, has been proposed to play an important role in oxidative stress in AD brain and could be one of the key factors in the pathogenesis of AD. In the present review, we discuss some of the AD animal models that express AP, and compare the proteomics-identified oxidatively modified proteins between AD brain and those of AP models. Such a comparison would allow better understanding of the role of AP in AD pathogenesis thereby helping in developing potential therapeutics to treat or delay AD.
引用
收藏
页码:685 / 696
页数:12
相关论文
共 50 条
  • [1] Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease
    Mark, RJ
    Blanc, EM
    Mattson, MP
    MOLECULAR NEUROBIOLOGY, 1996, 12 (03) : 211 - 224
  • [2] Oxidative stress and the amyloid beta peptide in Alzheimer's disease
    Cheignon, C.
    Tomas, M.
    Bonnefont-Rousselot, D.
    Faller, P.
    Hureau, C.
    Collin, F.
    REDOX BIOLOGY, 2018, 14 : 450 - 464
  • [3] Cellular targets for amyloid beta-peptide in Alzheimer's disease
    Yan, SD
    Stern, D
    Arrancio, O
    Li, LF
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S285 - S285
  • [4] The molecular significance of amyloid beta-peptide for Alzheimer's disease
    Haass, C
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1996, 246 (03) : 118 - 123
  • [5] Redox proteomics and amyloid β-peptide: insights into Alzheimer disease
    Butterfield, D. Allan
    Boyd-Kimball, Debra
    JOURNAL OF NEUROCHEMISTRY, 2019, 151 (04) : 459 - 487
  • [6] Effects of racemization on the aggregational properties of the amyloid beta-peptide in Alzheimer's disease
    Yang, J
    Hong, A
    Zagorski, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 255 - MEDI
  • [7] Animal Models of Alzheimer’s Disease: Utilization of Transgenic Alzheimer’s Disease Models in Studies of Amyloid Beta Clearance
    Tarja Malm
    Johanna Magga
    Jari Koistinaho
    Current Translational Geriatrics and Experimental Gerontology Reports, 2012, 1 (1): : 11 - 20
  • [8] The role of oxidative stress in the toxicity induced by amyloid β-peptide in Alzheimer's disease
    Miranda, S
    Opazo, C
    Larrondo, LF
    Muñoz, FJ
    Ruiz, F
    Leighton, F
    Inestrosa, NC
    PROGRESS IN NEUROBIOLOGY, 2000, 62 (06) : 633 - 648
  • [9] Animal Models of Alzheimer's Disease: Utilization of Transgenic Alzheimer's Disease Models in Studies of Amyloid Beta Clearance
    Malm, Tarja
    Magga, Johanna
    Koistinaho, Jari
    CURRENT GERIATRICS REPORTS, 2012, 1 (01): : 11 - 20
  • [10] The interaction between apolipoprotein E and Alzheimer's amyloid beta-peptide is dependent on beta-peptide conformation
    Golabek, AA
    Soto, C
    Vogel, T
    Wisniewski, T
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (18) : 10602 - 10606